Two of the most studied recovery-oriented research peptides, compared across mechanism, pharmacokinetics, research applications, and cost — so you can make an informed decision for your study protocol.
In Plain English — What's the Actual Difference?
BPC-157 is a precision tool: it targets specific local areas — particularly the gut, tendons, and nervous system — and essentially tells your body to build new blood vessels and repair tissue at that site. TB-500 is more systemic: it promotes cell migration and reduces inflammation throughout the body.
Mechanisms of Action
BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a protective protein isolated from human gastric juice. Its primary mechanism involves upregulation of VEGFR-2 and activation of EGR-1. TB-500 is the synthetic fragment of Thymosin Beta-4 that binds actin and promotes cell migration.
Side-by-Side Specifications
Molecular weight, half-life, primary mechanism, research applications, evidence level, and typical research dose compared for BPC-157 vs TB-500 — with stacking rationale for the Wolverine Blend combination.